AtaiBeckley (ATAI) Accumulated Expenses (2020 - 2026)

AtaiBeckley (ATAI) recorded quarterly Accumulated Expenses of $3.9 million in Q1 2026, down 31.0% quarter-over-quarter from $5.7 million in Q4 2025.

AtaiBeckley (ATAI) Accumulated Expenses (2020 - 2026) Analysis & Trends

AtaiBeckley's Accumulated Expenses history runs 3 years deep, the most recent figure standing at $3.9 million for Q1 2026.

  • In Q1 2026, Accumulated Expenses changed N/A year-over-year to $3.9 million; the TTM figure through Mar 2026 stood at $3.9 million (changed N/A YoY), while the FY2025 annual figure was $5.7 million, up 49.66% from the prior year.
  • Accumulated Expenses was $3.9 million for Q1 2026 at AtaiBeckley, down from $5.7 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $18.9 million in Q2 2022 to a low of $1.1 million in Q1 2022.
  • The 5-year median for Accumulated Expenses is $8.3 million (2021), against an average of $8.1 million.
  • Biggest YoY gain for Accumulated Expenses was 49.66% in 2025; the steepest drop was 49.66% in 2025.
  • A 3-year view of Accumulated Expenses shows it stood at $3.8 million in 2024, then jumped by 49.66% to $5.7 million in 2025, then sank by 31.0% to $3.9 million in 2026.
  • The last three Accumulated Expenses figures came in at $3.9 million (Q1 2026), $5.7 million (Q4 2025), and $3.8 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 AtaiBeckley 1.45 Bn 1.45 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 3.90 Mn
Dec 31, 2025 5.65 Mn
Sep 30, 2025 10.46 Mn
Jun 30, 2025 3.83 Mn
Mar 31, 2025 8.68 Mn
Dec 31, 2024 3.78 Mn
Dec 31, 2024 9.85 Mn
Sep 30, 2024 2.35 Mn
Jun 30, 2024 12.91 Mn
Mar 31, 2024 1.65 Mn
Dec 31, 2023 15.26 Mn
Sep 30, 2023 13.01 Mn
Jun 30, 2023 12.86 Mn
Mar 31, 2023 13.82 Mn
Dec 31, 2022 5.26 Mn
Sep 30, 2022 3.99 Mn
Jun 30, 2022 18.91 Mn
Mar 31, 2022 1.11 Mn
Dec 31, 2021 2.83 Mn
Sep 30, 2021 1.39 Mn